The Clinion EDC platform is being offered to researchers at a discounted price in their fight against the Covid-19 virus. As of May 15, Clinion is already supporting multiple Covid-19 studies.
We have developed a mobile Patient Reported Outcomes (ePRO) application within a span of 2 weeks to manage decentralized patient participation and remote monitoring of subjects.
The mobile platform takes care patient enrolment, eConsent and Symptom tracking. The mobile application is integrated with Clinion’s Electronic Data
Capture (EDC) system. Investigators and study personnel can monitor patients in real-time and reach out to them proactively.
Clinion EDC and ePRO mobile platform is available for researchers around the
world for rapidly configuring and deploying Covid-19 studies.